...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Shareholder Value
8
Aug 06, 2021 10:32AM
1
Aug 06, 2021 09:33PM
6
Aug 06, 2021 10:09PM

Much appreciated, Nextblockbuster!  I too have picked up shares on the OTC. Albeit somewhat nervously. ;)

2
Aug 07, 2021 12:02PM
6
Aug 07, 2021 01:41PM
1
Aug 07, 2021 01:43PM
Share
New Message
Please login to post a reply